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Abstract 
In order to gain insight into the mechanistic role of a flexible exterior loop near the active site, made up 
of Y62, H63, G64, and Y65, that has been proposed to play an important role in substrate binding and 
recognition in the methionyl aminopeptidase from Escherichia coli(EcMetAP-I), the H63A enzyme was 
prepared. Mutation of H63 to alanine does not affect the ability of the enzyme to bind divalent metal 
ions. The specific activity of H63A EcMetAP-I was determined using four different substrates of varying 
lengths, namely, L-Met-p-NA, MAS, MGMM and MSSHRWDW. For the smallest/shortest substrate (L-
Met-p-NA) the specific activity decreased nearly seven fold but as the peptide length increased, the 
specific activity also increased and became comparable to WT EcMetAP-I. This decrease in specific 
activity is primarily due to a decrease in the observed kcat values, which decreases nearly sixty-fold for L-
Met-p-NA while only a four-fold decrease is observed for the tri- and tetra-peptide substrates. 
Interestingly, no change in kcat was observed when the octa-peptide MSSHRWDW was used as a 
substrate. These data suggest that H63 affects the hydrolysis of small peptide substrates whereas large 
peptides can overcome the observed loss in binding energy, as predicted from Km values, by 
additional hydrophilic and hydrophobic interactions. 
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Methionine aminopeptidases (MetAPs) represent a unique class of protease that are responsible for 
removing the N-terminal methionine residue from proteins and polypeptide chains [1], [2], [3], [4], [5]. 
Methionine free N-termini have been postulated to be important for additional protein processing to 
occur, such as removal of signal sequences (if present), proteolytic cleavage to generate shorter 
peptides, or the covalent attachment of residues and blocking groups such as acetyl and myristoyl 
groups [1]. MetAPs are therefore one of the key cellular enzymes involved in protein maturation [5], [6]. 
The physiological importance of MetAP is underscored by the lethality of the absence of all the genes or 
the gene products in Escherichia coli (EcMetAP-I), Salmonella typhimurium and Saccharomyces 
cerevisiae[7], [8], [9], [10]. Moreover, based on fumagillin affinity chromatography and mass spectrometry, 
MetAPs were identified as the molecular targets of fumagillin and TNP-470 [11], [12]. In vivo studies 
showed that one of the observed effects of inhibiting MetAPs by anti-angiogenesis agents is the failure 
to expose glycine residues at the N-termini of certain signaling proteins involved in cell cycle regulation, 
which prevents myristolyation [13]. Therefore, MetAPs represent an extremely promising target for the 
design of a novel class of anti-angiogenesis drugs, some of which are currently under clinical 
investigation [11], [14], [15], [16], [17], [18], [19]. 
MetAPs are organized into two classes (types-I and -II) based on the absence or presence of an extra 62 
amino acid sequence (of unknown function) inserted near the catalytic domain. The type-I MetAPs 
from E. coli (EcMetAP-I), Staphylococcus aureus (SaMetAP-I), Homo sapiens(HsMetAP-I), 
and Thermotoga maritima (TmMetAP-I) and the type-II MetAPs from H. sapiens (HsMetAP-II) 
and Pyrococcus furiosus (PfMetAP-II) have been crystallographically 
characterized [17], [20], [21], [22], [23], [24], [25], [26]. All six display a novel “pita-bread” fold with an internal pseudo 
two-fold symmetry that structurally relates the first and second halves of the polypeptide chain to each 
other. Each half contains an antiparallel β-pleated sheet flanked by two helical segments and a C-
terminal loop. Both domains contribute conserved residues to the metallo-active site. In all six 
structures, a bis(μ-carboxylato)(μ-aquo/hydroxo)dicobalt core is observed with an additional 
carboxylate residue at each metal site and a single histidine bound to Co1. Recently, an X-ray crystal 
structure of EcMetAP-I was reported with partial occupancy (40%) of a single Mn(II) ion bound in the 
active site [27]. This structure was obtained by adding the transition-state analog inhibitor l-norleucine 
phosphonate (l-NleP), in order to impede divalent metal binding to the second site, and by limiting the 
amount of metal ion present during crystal growth. This structure provides the first structural 
verification that MetAPs can form mononuclear active sites and the single divalent metal ion resides the 
H171 side of the active site as previously predicted by 1H NMR and EXAFS spectroscopy [28], [29]. 
All MetAPs appear to have similar substrate specificities that are dictated by the penultimate residue. 
MetAPs will only remove N-terminal methionine residues from polypetide chains (P1) and only if the 
amino acid residue adjacent to the N-terminal methionine (P1′) is physically small and/or uncharged 
(e.g. G, A, P, S, T, C and V) [30]. MetAP substrate preference is opposite to the “N-end rule” for protein 
degradation since MetAPs will not remove an N-terminal methionine if a “destabilizing” amino acid will 
be exposed [31], [32]. In cases where the N-terminal methionine residue is retained, it has been postulated 
to act as a prophylactic cap preventing premature degradation [31], [32]. At this time it is unclear whether 
MetAPs have P2′ or P3′ recognition sites, but in previous studies with the substrate MSSHRWDW that 
has six residues downstream from the P1′ site, the Michaelis–Menten constant (Km) was found to be 
∼ 10 and ∼ 3 orders of magnitude lower compared to three- and four-residue substrates, 
respectively [33]. A flexible loop near the active site of all bacterial MetAPs, made up of Y62, H63, G64, 
and Y65 (E. coli numbering) has been proposed to play an important role in substrate binding and 
recognition and may provide a route to selective inhibition of bacterial vs. mammalian MetAP 
enzymes [22], [25]. In EcMetAP-I, H63 appears to form a “cap” over the substrate binding channel (Figs. 1A, 
B) [22]. The histidine at position-63 is strictly conserved in gram-negative bacteria including 
enterobacteria while in gram-positive bacteria the histidine is replaced by tyrosine with the exception 
of SaMetAP-I, which has a glutamate at this position (Fig. 2). In order to investigate the role of this 
flexible loop in substrate recognition and catalysis we have prepared and characterized the 
H63A EcMetAP-I enzyme. 
 
Fig. 1. (A) Space-filling model of EcMetAP-I complexed with the substrate-analog inhibitor (3R)-amino-(2S)-
hydroxyheptanoyl-l-Ala-l-Leu-l-Val-l-Phe-OMe (PDB: 3MAT). Color coding: H63A (green, blue and red), S1 pocket 
residues (magenta), S2 pocket residues (dirty pink) and metal ions(pink). (B) EcMetAP-I active site complexed with 
the substrate-analog inhibitor (3R)-amino-(2S)-hydroxyheptanoyl-l-Ala-l-Leu-l-Val-l-Phe-OMe (PDB: 3MAT). The 
H63 residue is 3.66 Å from the third residue of the substrate-analog inhibitor. 
 
Fig. 2. Sequence alignment of select MetAP-Is. S1 pocket residues (green) (Ec) Escherichia. coli-I; 
(St) Salmonella typhimurium-I (all are enterobacteria) (Hi) Haemophilus. influenzae-I; (Hp) Helicobacter pylori-I; 
(Sc) Sacchromyce cerevisiae-I; (Hs) Homo sapiens-I; (Bs) Bacillus subtilis; (Sa) Staphylococcus aureus. 
1. Materials and methods 
1.1. Mutagenesis, protein expression and purification 
The H63A mutated form of EcMetAP-I was obtained by PCR mutagenesis using the following primers: 5′-
C CTC GGC TAT XXX GGC TAT CC-3′ and 5′-G GAG CCG ATA YYY CCG ATA GG-3′ with GCG for XXX and CGC 
for YYY, which encodes for the H63A mutant. The H63 site directed mutant was obtained using the 
Quick Change™ Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) following Stratagene's 
procedure. Reaction products were transformed into E. coliXL1-Blue competent cells (recA1 endA1 
gyrA96 thi-1 hsdR17supE44 relA1 lac [F′proAB lacIqZΔM15 Tn10 (Tetr)]), grown on LB-agar plates 
containing kanamycin at a concentration of 50 μg/ml. A single colony of the mutant was grown in 50 ml 
LB containing 50 μg/ml of kanamycin. Plasmids were isolated using Wizard Plus Minipreps DNA 
purification kit (Promega, Madison, WI) or Qiaprep® Spin Miniprep kit (Qiagene, Valencia, CA). The 
mutation was confirmed by DNA sequencing. Plasmids containing the mutated EcMetAP-I gene were 
transformed into E. coli BL21 Star™(DE3) (F− ompT hsdSB (rB−mB−) gal dcm rne131(DE3)) (Invitrogen, 
Carlsbad, CA) and stock cultures prepared. The variant was purified identical to the wild-type EcMetAP-I 
enzyme [16], [28]. Purified H63A EcMetAP-I exhibited a single band on SDS-PAGE at Mr of 29,630. Protein 
concentrations were estimated from the absorbance at 280 nm using an extinction coefficient of 
16,445 M− 1cm− 1[34]. Apo-H63A EcMetAP-I was washed free of methionine using Chelex-100 treated 
methionine-free buffer (25 mM HEPES, pH 7.5, 150 mM KCl) and concentrated by microfiltration using a 
Centricon-10 (Amicon, Beverly, MA) prior to all kinetic assays. Individual aliquots of apo-H63A EcMetAP-I 
were routinely stored at − 80 °C or in liquid nitrogen until needed. 
1.2. Metal content measurements 
H63A EcMetAP-I enzyme samples used in metal analyses were typically 30 μM. Apo-H63A EcMetAP-I 
was incubated anaerobically with Co(II) (CoCl2: ≥ 99.999% Strem Chemicals, Newburyport, MA) for 
30 min prior to exhaustive anaerobic exchange into Chelex-100 treated HEPES buffer as previously 
reported [28]. Metal analyses were performed using inductively coupled plasma-atomic emission 
spectrometry (ICP-AES). 
1.3. Discontinuous enzymatic assay of H63A EcMetAP-I 
Enzymatic assays of H63A EcMetAP-I were performed under strict anaerobic conditions in an inert 
atmosphere glove box (Ar/5% H2, ≤ 1 ppm O2; Coy Laboratories) with a dry bath incubator to maintain 
the temperature. Catalytic activities were determined with an error of ± 5% in 25 mM HEPES buffer, pH 
7.5, containing 150 mM KCl. The amount of product formation was determined by high-performance 
liquid chromatography (HPLC, Shimadzu LC-10A class-VP5). A typical assay involved the addition of 8 μL 
of Co(II)-loaded H63A EcMetAP-I to a 32 μL substrate-buffer mixture at 30 °C for 1 min. The reaction was 
quenched by the addition of 40 μL of 1% trifluoroacetic acid solution (TFA). Elution of the product was 
monitored at 215 nm following separation on a C8 HPLC column (Phenomenex, Luna; 5 μm, 
4.6 × 25 cm), as previously described [28]. 
1.4. Spectrophotometric enzymatic assay of H63A EcMetAP-I 
A typical reaction with l-Methionine-p-nitroaniline (l-Met-p-NA) as the substrate was carried out at 30 °C 
in a narrow path (∼ 100 μL) quartz cuvette containing 25 mM HEPES buffer, pH 7.5, and 150 mM KCl in a 
Shimadzu UV-3101PC spectrophotometer equipped with a constant-temperature cell holder and an 
Isotemp 2013D water bath (Fisher Scientific, Pittsburgh,PA). The rate for background hydrolysis of the 
substrate was measured by monitoring the formation of p-NA continuously at 405 nm 
(ɛ = 10,800 M− 1 cm− 1) in a cell with a 1 cm light path for 10 min. The enzymatic reaction was initiated by 
the addition of Co(II)-loaded WT and H63A EcMetAP-I and the progress curves were monitored at 
405 nm [35]. 
1.5. Isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) measurements were carried out on a MicroCal OMEGA 
ultrasensitive titration calorimeter. The divalent metal ion (CoCl2) titrant and apo-H63A EcMetAP-I 
solutions were prepared in Chelex-100 treated 25 mM HEPES buffer, pH 7.5, and 150 KCl. Stock buffer 
solutions were thoroughly degassed before each titration. The enzyme solution (70 μM) was placed in 
the calorimeter cell and stirred at 200 rpm to ensure rapid mixing. Typically, 3 μL of titrant was delivered 
over 7.6 s with a 5 min interval between injections to allow for complete equilibration. Each titration 
was continued until 4.5–6 equivalents. of Co(II) had been added to ensure that no additional complexes 
were formed in excess titrant. A background titration, consisting of the identical titrant solution but only 
the buffer solution in the sample cell, was subtracted from each experimental titration to account for 
heat of dilution. The data were analyzed with a two or three-site binding model by the Windows-based 
Origin software package supplied by MicroCal [36]. The equilibrium binding constant, Ka, and the enthalpy 
change ΔH, were used to calculate ΔG and ΔS using the Gibbs free energy relationship (Eq. (1)): 
∆𝐺𝐺 = −𝑅𝑅𝑅𝑅 ln[𝑘𝑘𝑎𝑎] = ∆𝐻𝐻° −  𝑅𝑅∆𝑆𝑆° (1) 
where R = 1.9872 cal mol− 1 K− 1. The relationship between Ka and Kd is defined as: 
𝐾𝐾𝑑𝑑 = 1/𝑘𝑘𝑎𝑎 (2) 
1.6. Spectroscopic measurements 
Electronic absorption spectra were recorded on a Shimadzu UV-3101PC spectrophotometer. The apo-
H63A EcMetAP-I samples used in spectroscopic measurements were made rigorously anaerobic prior to 
incubation with Co(II) (CoCl2: ≥ 99.999% Strem Chemicals, Newburyport, MA) for ∼ 30 min at 20–25 °C. 
Co(II)-containing samples were handled throughout in an anaerobic glove box (Ar/5% H2, ≤ 1 ppm O2; 
Coy Laboratories) until frozen. Electronic absorption spectra were normalized for the protein 
concentration and the absorption due to uncomplexed Co(II) (ɛ512 nm = 6.0 M− 1 cm− 1) [28]. Low-
temperature EPR spectroscopy was performed using a Bruker ESP-300E spectrometer equipped with an 
ER 4116 DM dual mode X-band cavity and an Oxford Instruments ESR-900 helium flow cryostat. 
Background spectra recorded on a buffer sample were aligned with and subtracted from experimental 
spectra as in earlier work [37], [38]. EPR spectra were recorded at microwave frequencies of approximately 
9.65 GHz: precise microwave frequencies were recorded for each individual spectrum to ensure 
precise g-alignment. All spectra were recorded at a 100 kHz modulation frequency. Other EPR running 
parameters are specified in the figure legends for individual samples. EPR simulations were carried out 
using matrix diagonalization (XSophe, Bruker Biospin), assuming a spin 
Hamiltonian H = βg · H · S + S · D · S + S · A · I, with S = 3/2 and D ≫ βgHS (= hν), where all of the variables 
have their usual meanings [39]. H63A EcMetAP-I enzyme concentrations for EPR were ∼ 1 mM and 
samples were frozen after incubation of with the appropriate amount of metal ion for 60 min at 25 °C. 
2. Results 
2.1. Metal content of H63A EcMetAP-I 
The number of tightly bound divalent metal ions was determined for H63A EcMetAP-I by ICP-AES 
analysis. Apo-enzyme samples (30 μM), to which 2–30 equivalents of Co(II) were added under anaerobic 
conditions, were dialyzed extensively for 3 h at 4 °C with Chelex-100 treated, metal-free HEPES buffer 
(25 mM HEPES, 150 mM KCl, pH 7.5). ICP-AES analysis revealed 1.0 ± 0.1 equivalent of cobalt associated 
with the H63A EcMetAP-I enzyme. 
2.2. Kinetic properties of H63A EcMetAP-I 
Kinetic parameters were determined for the Co(II)-loaded H63A EcMetAP-I enzyme using l-Met-p-NA, 
MAS, MGMM, and MSSHRWDW as substrates (Table 1). Activity assays were performed in triplicate for 
8–15 concentrations of each substrate (l-Met-p-NA 0 to 5 mM; MAS, 0–60 mM; MGMM, 0–12 mM; 
MSSHRWDW, 0–12 mM). For l-Met-p-NA, product formation was monitored spectrophotometrically at 
405 nm [35]while product was quantified by HPLC for MAS, MGMM, and MSSHRWDW. 
Both Km and kcat values were obtained by nonlinear fitting of these data to the Michaelis–Menten 
equation. The observed Km values for WT EcMetAP-I decreased in the order 
MAS > MGMM > MSSHRWDW > l-Met-p-NA (Table 1). For WT EcMetAP-I, the observed kcat values 
increased in the order l-Met-p-NA ≪ MAS < MGMM < MSSHRWDW (Table 1). Because the 
observed kcat value is significantly smaller for l-Met-p-NA vs. the other three substrates used, the 
catalytic efficiencies (kcat/Km) increase in the order l-Met-p-NA < MAS < MGMM < MSSHRWDW (Table 1). 
A similar trend was observed for kcat values obtained for H63A EcMetAP-I (l-Met-p-
NA ≪ MAS < MGMM < MSSHRWDW) except that the observed kcatvalues for H63A EcMetAP-I were ∼ 60 
times lower for l-Met-p-NA but only ∼ 4-fold lower for MAS and MGMM (Table 1). However, the 
observed kcat value for the hydrolysis of MSSHRWDW by H63A EcMetAP-I was identical, within error, to 
WT EcMetAP-I (Table 1). The observed Km values for H63A EcMetAP-I decreased in the order 
MAS > MGMM > MSSHRWDW > l-Met-p-NA (Table 1). Interestingly, the observed Km for MAS increased 
to 15 from 12 mM while that of l-Met-p-NA decreased slightly from 0.44 to 0.33 μM. The 
observed Kmvalues for MGMM and MSSHRWDW were identical, within error, to those obtained for 
WT EcMetAP-I [28]. 
Table 1. Kinetic constants for Co(II)-loaded EcMetAP-I for various substrates at 30 °C 
Enzyme Kinetic constants   L-Met-p-NA MAS MGMM MSSHRWDW 
WT Km (mM)   0.44 ± 0.03 12.0 ± 0.1 3.0 ± 0.1 1.0 ± 0.1 
EcMetAP-I kcat (s− 1)   0.006 ± 0.003 11.0 ± 0.3 18.3 ± 0.3 84 ± 1.0 
  kcat/Km (M− 1 s− 1) 13.7 920 6100 84,000 
  SA (U/mg)   0.013 ± 0.003 20.5 ± 1.0 36.0 ± 3.0 167 ± 8.0 
H63A Km (mM)   0.33 ± 0.02 15.0 ± 0.1 3.1 ± 0.3 1.0 ± 0.1 
EcMetAP-I kcat (s− 1)   0.0001 ± 0.00005 3.0 ± 0.3 4.8 ± 0.3 70 ± 1.0 
  kcat/Km (M− 1 s− 1) 3.0 200 1532 70,000 
  SA (U/mg)   0.002 ± 0.001 7.5 ± 1.0 9.5 ± 1.0 140 ± 9.0 
 
2.3. Metal binding properties of H63A EcMetAP-I 
In order to determine the number of tight metal binding sites and the affinity of these sites, both activity 
titrations and isothermal titration calorimetry (ITC), were used. The extent of hydrolytic activity 
exhibited by the H63A EcMetAP-I enzyme was examined as a function of Co(II) concentration with both 
MGMM and l-Met-p-NA as substrates (Fig. 3; inset). The apo-H63A EcMetAP-I enzyme was incubated for 
30 min under strict anaerobic conditions at pH 7.5 with Co(II) (0 to 200 equivalents) after 
which kcat values were obtained. The kcat value increased as a function of Co(II) ion concentration and 
exhibited a maximum after the addition of only one equivalent of Co(II). Further additions of Co(II) 
resulted in little change in the observed kcat value until four equivalents of Co(II) has been added. At this 
point, the addition of Co(II) became inhibitory. These data were fit to Eq. (3) (Fig. 3) [40]: 
𝑟𝑟 = 𝑝𝑝𝐶𝐶𝑆𝑆/(𝐾𝐾𝑑𝑑 + 𝐶𝐶𝑆𝑆) (3) 
where p is the number of sites for which interaction with a ligand is governed by the intrinsic 
dissociation constant Kd, CS is the free metal concentration (Cofree in this case), and r is the binding 
function that was calculated by conversion of the fractional saturation (fa) as previously described [28]. 
The free metal concentration was calculated from: 
𝐶𝐶𝑆𝑆 = 𝐶𝐶𝑇𝑇𝑆𝑆 − 𝑟𝑟𝐶𝐶𝐴𝐴 (4) 
where CTS and CA are the total molar concentrations of metal and enzyme, respectively. The best fit 
obtained with either MGMM or l-Met-p-NA provided a p value of 1 and a Kd value of 0.15 μM (Fig. 3). 
 
Fig. 3. Plot of binding function, r vs. CS for the binding of Co(II) to H63A EcMetAP-I using MGMM as the substrate 
in HEPES buffer at pH 7.5. The solid line is a fit to Eq. (3). Inset: plot of specific activity of vs. equivalents of added 
Co(II) ions. 
Confirmation of the Kd value determined from enzymatic activity titrations for Co(II) binding to 
H63A EcMetAP-I was obtained via ITC (Fig. 4). All ITC experiments were carried out at 25 ± 0.2 °C and 
association constants (Ka) were obtained by fitting these data, after subtraction of the background heat 
of dilution, via an iterative process using the Origin software package. This software package uses a 
nonlinear least-squares algorithm, which allows the concentrations of the titrant and the sample to be 
fit to the heat-flow-per-injection to an equilibrium binding equation for two non-interacting sites. 
The Kavalue, enzyme-metal stoichiometry (n), and the change in enthalpy (ΔH°) were allowed to vary 
during the fitting process (Table 2, Fig. 4). The best fit obtained for H63A EcMetAP-I provided an 
overall n value of 3 for two noninteracting sites, identical to WT EcMetAP-I. Attempts to fit these data 
with n values of 1 or 2 provided poor fits. For H63A EcMetAP-I, a Kdvalue of 5.8 ± 1.2 μM was observed 
as well as two Kd values of 7.0 ± 2.4 mM (Table 2). The first Co(II) binding event for H63A EcMetAP-I was 
weakly endothermic while the second and third Co(II) binding events were significantly more 
endothermic. 
 
Fig. 4. (Top) ITC titration of a 70 μM solution of H63A EcMetAP-I with a 5 mM Co(II) solution. (Bottom) Fit of the ITC 
data for H63A EcMetAP-I. The fits were obtained using noninteracting sites model and provided an overall n value 
of 3, with one tight and two loose sites. Reaction conditions: 20 °C in 25 mM HEPES, pH 7.5, and 150 mM KCl. 
Table 2. Dissociation constants (Kd), metal-enzyme stoichiometry (n) and thermodynamic parameters for 
Co(II) binding to both WT and H63A EcMetAP-I 
Enzyme n Kd1, Kd2 
(μM) 
ΔH1, ΔH2 
(kcal/mol) 
TΔS1, TΔS2 
(kcal/mol) 
ΔG1, ΔG2 
(kcal/mol) 
WT EcMetAP-I 1 6.4 15.4 20.3 − 7.9 
  2 14,000 1060 1060 − 2.5 
H63A EcMetAP-I 1 5.8 1.19 8.29 − 7.1 
  2 7000 65.8 68.7 − 2.9 
 
2.4. Spectroscopic studies of Co(II)-loaded H63A EcMetAP-I 
The electronic absorption spectra of H63A EcMetAP-I, after the addition of one and two equivalents of 
Co(II), were recorded under strict anaerobic conditions in 25 mM HEPES buffer, pH 7.5 and 150 mM KCl 
(Fig. 5). The addition of one and two equivalents of Co(II) to apo-H63A EcMetAP-I provided a complex 
spectra comprised of at least four bands between 500 and 700 nm with extinction coefficients ranging 
from 60 to 20 M− 1 cm− 1. The EPR spectrum of a 1.5 mM H63A EcMetAP-I sample in 25 mM HEPES, pH 
7.5, and 150 mM KCl after the addition of 1 and 2 equivalents of Co(II) were indistinguishable from each 
other and from the corresponding spectra exhibited by WT Co(II)-loaded EcMetAP-I (Figure S1) [28]. The 
spectrum of [CoCo(H63A-EcMetAP-I)] accounted for 100% ± 5% of the added Co(II). The spectrum was 
broad (line widths > 500 G) and exhibited no resolvable 59Co hyperfine splitting, presumably due to the 
extensive strains in g and zero-field splitting parameters sometimes associated with high-spin S = 3/2 
Co(II) centers. 
 
Fig. 5. Electronic absorption spectra of a 1 mM H63A EcMetAP-I sample in 25 mM HEPES, pH 7.5, 150 mM KCl in 
the presence of 0.5 (red), 1.0 (green), 1.5 (blue), and 2 (black) equivalents of Co(II) at 25 °C. 
3. Discussion 
MetAPs exhibit exclusive specificity for methionine residues located at the N-terminus of proteins and 
polypeptides [1], [2], [3], [4], [5]. All MetAPs appear to have similar substrate specificities, [5], [30], in that 
MetAPs will only cleave N-terminal methionine residues that are adjacent to physically small and/or 
uncharged residues (e.g. G, A, P, S, T, C and V) [30]. In EcMetAP-I, the S1 pocket is created by surface 
loops that include residues 59–68 and 221–224. The proposed substrate specificity pocket is lined by the 
hydrophobic residues C59, C70, Y62, Y65, Y168, F177, M206, W221, and Q233 [22], [41]. Based on 
molecular modeling studies and sequence comparisons a flexible exterior loop near the active site 
of EcMetAP-I was identified, which is made up of Y62, H63, G64, and Y65. This loop has been proposed 
to play an important role in substrate binding and recognition and hence may regulate the type of N-
terminal amino acid residue that is capable of binding to MetAPs. Inspection of the six X-ray crystal 
structures of MetAPs that have been reported thus far, reveal that a planar amino acid residue such as 
histidine (H63) or tyrosine forms a “cap” over the S1 pocket [17], [20], [21], [22], [23], [24], [25]. While this residue is 
not formally a member of the S1 binding pocket, it resides on a flexible surface loop and therefore may 
swing open or closed, thus regulating substrate binding. Based on X-ray crystal structures of EcMetAP-I, 
residues in this flexible loop directly interact with active site bound inhibitors [22], [41]. In order to 
investigate the role of H63 in substrate recognition and binding as well as its affect on the hydrolysis 
reaction catalyzed by EcMetAP-I, we have generated the H63A EcMetAP-I enzyme. 
The specific activity of H63A EcMetAP-I was determined using four different substrates of varying 
lengths, namely, l-Met-p-NA, MAS, MGMM and MSSHRWDW [33]. For the smallest/shortest substrate (l-
Met-p-NA) the specific activity decreased nearly seven-fold. However, as the peptide length increased 
the specific activity also increased with H63A EcMetAP-I exhibiting nearly full activity towards the octa-
peptide MSSHRWDW. The observed decrease in specific activity is primarily due to a decrease 
in kcat values, which drop nearly sixty-fold for l-Met-p-NA but only four-fold for the tri- and tetra-peptide 
substrates. Interestingly, no change in kcat was observed when the octa-peptide MSSHRWDW was used 
as a substrate. Surprisingly, the H63A EcMetAP-I enzyme could not hydrolyze l-Ala-p-NA or l-Leu-p-NA. 
These data indicate that as the peptide length increases, the effect of altering H63 on the catalytic 
process diminishes. Therefore, the observed kinetic changes are likely due to the lack of pre-
organization of substrate and nucleophile for short peptides in the absence of H63. This conclusion is 
consistent with X-ray crystal structures of EcMetAP-I which show that H63 forms direct contacts with 
inhibitor molecules bound in the active site [22], [41]. Long peptides can overcome this lost interaction with 
H63 by added hydrophobic and hydrophilic bonding interactions, thereby decreasing the degree of 
positional and vibrational freedom. 
Interestingly, kcat/Km values, which are a measure of substrate capture, follow an opposite trend to the 
observed kcat values. For the smallest substrates, l-Met-p-NA and MAS, the observed kcat/Km values 
decrease ∼ 4.6-fold while MGMM decrease ∼ 4.1-fold compared to WT EcMetAP-I. However, for the 
longest peptide substrate, MSSHRWDW, the observed kcat/Km values are nearly identical to 
WT EcMetAP-I. Even though the kcat and Km values for the four substrates tested are markedly affected 
by the elimination of H63, no major geometrical changes around the active site Co(II) ions are observed, 
based on electronic absorption and EPR spectra of Co(II)-loaded H63A EcMetAP-I. These data indicate 
that H63 plays a role in substrate binding but that its role can be overcome when a longer peptide is 
used since the loss of one protein-substrate interaction can be overcome by many additional 
interactions. Additional insight into protein-substrate interactions can be gleaned from the X-ray crystal 
structure of a substrate-analog inhibitor ((3R)-amino-(2S)-hydroxyheptanoyl-l-Ala-l-Leu-l-Val-l-Phe-OMe) 
bound to EcMetAP-I (Figs. 1A, B). In this structure, the N-terminus of the inhibitor is coordinated to Co2, 
the keto oxygen (analogous to the carbonyl carbon in a terminal peptide bond) is ligated to Co1 and the 
(2S)-hydroxyl group displaces the bridging water/hydroxide ion [22], [41]. The third residue, l-Leu, resides 
3.7 Å away from H63 suggesting the formation of a hydrophobic interaction. Since the l-Leu side-chain 
resides in the S2 or S3 recognition pocket, the Km values for long peptides are not greatly affected, as 
observed, since many additional hydrophilic and/or hydrophobic interactions exist. However, the loss of 
H63 would open up the S1 and S2 pockets to the solvent, which may allow new hydrophilic and/or 
hydrophobic interactions resulting in tighter substrate binding. 
Recently, the X-ray crystal structure of SaMetAP-I complexed with keto heterocycle or amino ketone 
inhibitors, revealed that the analogous residue to H63 in SaMetAP-I becomes ordered and adopts a fixed 
conformation upon inhibitor binding [20]. The adopted conformation enlarged the S1 pocket and allowed 
the methyl group in the methionine side chain of each inhibitor to adopt different orientations 
corresponding to the possible rotamers [20]. Further inspection of the X-ray crystal structures of 
WT EcMetAP-I in the absence and presence of (3R)-amino-(2S)-hydroxyheptanoyl-l-Ala-l-Leu-l-Val-l-Phe-
OMe, suggest that H63 is quite labile and can adopt different conformations [22], [41]. However, upon 
inhibitor binding the resulting hydrophobic interaction between H63 and l-Leucine forces the histidine 
residue to adopt a fixed conformation [22]. Therefore, H63 likely plays a role in positioning the substrate 
as well as releasing the leaving group from the enzyme after hydrolysis has occurred. This proposal is 
also consistent with a previous report where H63 was mutated to leucine, resulting in no loss in the 
catalytic activity for EcMetAP-I using MGMM as the substrate [42]. Combination of these data suggests 
that a large, planar side chain is important at position 63 in EcMetAP-I and is also consistent with the 
observation that H63 (or a Y) is conserved in bacterial MetAP sequences (Fig. 2). Interestingly, in the 
mammalian type-I MetAP enzyme the corresponding loop containing the H63 residue is buried by an N-
terminal extension, resulting in a decrease in flexibility for this loop [25]. Therefore, residues in this loop 
may provide a target for differentiating bacterial type-I enzymes from their mammalian counterparts. 
The metal binding and structural properties of the H63A EcMetAP-I enzyme were also investigated in 
order to ascertain whether alteration of H63 affects the dinuclear active site in EcMetAP-I. The 
H63A EcMetAP-I enzyme appears to bind one Co(II) ion tightly, similar to WT EcMetAP-I, while a second 
metal ion is labile on the time scale of the buffer exchange (3 h, 4 °C) [28]. Dissociation constants (Kd) for 
Co(II) binding to H63A EcMetAP-I were determined by both kinetic and ITC measurements. Based on an 
activity titration data, H63A EcMetAP-I is active after the addition of only one Co(II) ion, which binds 
with a Kdvalue of 0.15 μM, similar to WT EcMetAP-I [28]. On the other hand, the Kd values 
obtained via ITC for Co(II) binding to H63A EcMetAP-I was 5.8 μM, which is within error of that observed 
for WT EcMetAP-I. The larger Kd value observed using ITC is due to a decrease in dissociation which is 
typical when substrate can bind to the active site. The Kd value observed for the second metal binding 
event of H63A EcMetAP-I is ∼ 2-fold lower than that observed for WT EcMetAP-I. Even though the ΔG° 
values are identical for both the WT and the H63A EcMetAP-I, the ΔH° and TΔS° values are much lower 
for H63A EcMetAP-I then that observed for WT EcMetAP-I. These data correlate with activity 
measurements for H63A and WT EcMetAP-I and strongly suggest that the first metal binding site 
accommodates the catalytically relevant metal ion. This seemingly unexpected correlation, as H63 is not 
a direct ligand to the metal ions, underscores the importance of second-shell interactions in the active 
site of metalloenzymes. 
It should be noted, however, that activity assays carried out on H63A EcMetAP-I and WT EcMetAP-I used 
enzyme concentrations of ∼ 20 μM, which is two orders of magnitude larger than the Kd value 
determined for the first metal binding site of 0.2 or 0.4 μM assuming Hill coefficients of 1.3 and 2.1, 
respectively [43], [44]. However, a Kd value of between 2.5 and 4.0 μM was reported when it was assumed 
that only a single Co(II) binding site exists in the low concentration regime, which is within error of ITC 
derived Kd values. Under the conditions utilized, any cooperativity in divalent metal binding will not be 
detectable in ITC experiments due to high enzyme concentrations (∼ 70 μM) but may appear in EPR 
data. In fact, EPR data recorded on Mn(II)-loaded EcMetAP-I and PfMetAP-II suggests a small amount of 
dinuclear site formation even after the addition of only a quarter equivalent of Mn(II) [28], [45], [46]. Since 
activity titrations and ITC data are not particularly sensitive to the type of binding 
(i.e. cooperativity vs. two independent binding sites) the weak cooperativity observed by Larrabee et 
al.[43] and Hu et al. [44] would not be observed in these experiments but is entirely consistent with EPR 
data and, indeed, with the X-ray crystallographic data. Most X-ray structures of MetAPs were 
determined with a large excess of divalent metal ions so only dinuclear sites are observed. However, 
crystallographic data obtained on EcMetAP-I using metal ion:enzyme ratios of 0.5:1 reveals Mn(II) ion 
occupancies of 71% bound to the M1 site and 28% bound to the M2 site, consistent with cooperative 
binding [27]. 
In conclusion, combination of kinetic, ITC, and spectroscopic data has allowed the mechanistic role of 
H63 in EcMetAP-I to be examined. Alteration of H63 to an alanine residue primarily alters kcat but also 
affects the Km values of short peptide substrates. The observed change in kcat, and consequently Km, is 
likely due to the lack of pre-organization of substrate and nucleophile for short peptides in the absence 
of H63. Based on X-ray crystal structures of MetAP enzymes in the absence and presence of peptide 
inhibitors, H63 can form hydrophobic interactions with peptide bound to the dinuclear active site of 
MetAPs thereby adopting a more fixed conformation upon inhibitor binding. Since the dinuclear active 
site is not altered upon changing H63 to an alanine, the observed perturbations in kcat and Km are not 
due to interactions with the active site metal ions. These data indicate that the residues situated on the 
flexible loop made up of Y62, H63, G64, and Y65 do, in fact, play an important role in substrate binding 
and recognition in MetAP enzymes and may also provide a target with which to differentiate bacterial 
MetAPs from their mammalian counterparts. 
Appendix A. Supplementary data 
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